Clinical Trials Directory

Trials / Completed

CompletedNCT05901623

ASQ Scores of Transient Hypothyroxinemia of Prematurity

Neurodevelopmental Outcome of the Infants With Transient Hypothyroxinemia of Prematurity in Newborn Intensive Care Unit

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
Sex
All
Age
1 Month
Healthy volunteers
Accepted

Summary

• Transient hypothyroxinemia of prematurity (THoP) is defined as free thyroxine (FT4) level is below the reference values despite normal TSH level in preterm infant. This study aims to evaluate the neurological development of infants with transient premature hypothyroxinemia (THoP).

Conditions

Interventions

TypeNameDescription
OTHER'Ages and Stages Questionnaries' (ASQ)''ASQ' is a screening tool for assessing the development of infants and preschoolers in the areas of communication, fine motor, gross motor, problem-solving and personal-social development, and 'ASQ:SE' is a screening tool for social-emotional development

Timeline

Start date
2021-02-01
Primary completion
2022-03-01
Completion
2023-02-01
First posted
2023-06-13
Last updated
2023-06-15

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05901623. Inclusion in this directory is not an endorsement.

ASQ Scores of Transient Hypothyroxinemia of Prematurity (NCT05901623) · Clinical Trials Directory